Related references
Note: Only part of the references are listed.Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2012)
Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix
Robert J. Biggar et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia
M. Tailler et al.
ONCOGENE (2012)
An Immunosurveillance Mechanism Controls Cancer Cell Ploidy
Laura Senovilla et al.
SCIENCE (2012)
Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
Laurie Menger et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cells
Hosam A. Elbaz et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Trial Watch Adoptive cell transfer immunotherapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Trial watch Monoclonal antibodies in cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Trial Watch Immunostimulatory cytokines
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Trial watch Dendritic cell-based interventions for cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Trial Watch Experimental Toll-like receptor agonists for cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Trial watch Chemotherapy with immunogenic cell death inducers
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Trial watch Prognostic and predictive value of the immune infiltrate in cancer
Laura Senovilla et al.
ONCOIMMUNOLOGY (2012)
Trial watch Peptide vaccines in cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Trial watch FDA-approved Toll-like receptor agonists for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving High-Dose Therapy and Autologous Stem-Cell Transplantation
Lihua E. Budde et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Digoxin Use and the Risk of Breast Cancer in Women
Robert J. Biggar et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Contribution of IL-17-producing γδ T cells to the efficacy of anticancer chemotherapy
Yuting Ma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Sodium ion channel mutations in glioblastoma patients correlate with shorter survival
Avadhut D. Joshi et al.
MOLECULAR CANCER (2011)
Digitoxin-Induced Cytotoxicity in Cancer Cells Is Mediated through Distinct Kinase and Interferon Signaling Networks
Ioannis Prassas et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
I. Martins et al.
ONCOGENE (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment
Elizabeth A. Platz et al.
CANCER DISCOVERY (2011)
Ouabain - the insulin of the heart
H. Fuerstenwerth
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Pilot Study of Huachansu in Patients With Hepatocellular Carcinoma, Nonsmall-Cell Lung Cancer, or Pancreatic Cancer
Zhiqiang Meng et al.
CANCER (2009)
Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
Theocharis Panaretakis et al.
EMBO JOURNAL (2009)
Endogenous ouabain in cardiovascular function and disease
Paolo Manunta et al.
JOURNAL OF HYPERTENSION (2009)
Oleandrin-mediated inhibition of human tumor cell proliferation: importance of Na,K-ATPase α subunits as drug targets
Peiying Yang et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group
Michael B. Atkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cardiac glycosides as novel cancer therapeutic agents
Robert A. Newman et al.
MOLECULAR INTERVENTIONS (2008)
Novel therapeutic applications of cardiac glycosides
Ioannis Prassas et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells
Florence Lefranc et al.
NEUROSURGERY (2008)
Erlotinib exhibits antineoplastic off-target effects in AML and MDS:: a preclinical study
Simone Boehrer et al.
BLOOD (2008)
Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study
Thomas P. Ahern et al.
BREAST CANCER RESEARCH (2008)
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
IMMUNOLOGICAL REVIEWS (2007)
Digitoxin as an anticancer agent with selectivity for cancer cells:: possible mechanisms involved
Miguel Lopez-Lazaro
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib
Thibault de la Motte Rouge et al.
CANCER RESEARCH (2007)
The α1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers
T. Mijatovic et al.
JOURNAL OF PATHOLOGY (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Oleandrin induces apoptosis in human, but not in murine cells: Dephosphorylation of Akt, expression of FasL, and alteration of membrane fluidity
Pongali B. Raghavendra et al.
MOLECULAR IMMUNOLOGY (2007)
Phase 1 trial of Anvirzel™ in patients with refractory solid tumors
T Mekhail et al.
INVESTIGATIONAL NEW DRUGS (2006)
Sodium/potasium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides:: a new paradigm for development of anti-breast cancer drugs?
JQ Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
The Na/K-ATPase-mediated signal transduction as a target for new drug development
ZJ Xie et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Na/K-atpase, endogenous digitalis-like compounds and cancer development - A hypothesis
H Weidemann
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Up-regulation of Na+K+-ATPase α3-isoform and down-regulation of the α1-isoform in human colorectal cancer
H Sakai et al.
FEBS LETTERS (2004)
Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization
H Boukerche et al.
GENE (2004)
The contractile apparatus as a target for drugs against heart failure: Interaction of levosimendan, a calcium sensitiser, with cardiac troponin c
T Sorsa et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Analysis of the Na,K-ATPase α- and β-subunit expression profiles of bladder cancer using tissue microarrays
C Espineda et al.
CANCER (2003)
Enhancement of radiotherapy by oleandrin is a caspase-3 dependent process
S Nasu et al.
CANCER LETTERS (2002)
Anvinel™, an extract of Nerium oleander, induces cell death in human but not murine cancer cells
S Pathak et al.
ANTI-CANCER DRUGS (2000)
Share Paper
